PATENT CLAIM ANALYSIS

Application Number: 16090915
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "457000"]

Abstract:
The present invention relates to controlled release pharmaceutical formulations comprising an atypical antipsychotic agent such as Paliperidone in the form of capsule filled with mini-tablets that provide zero order drug release. It also relates to a process for the preparation thereof.

Claim (Index 10):
A controlled release formulation according to  claim 9 , wherein the methacrylic acid copolymer is present in an amount of 10-15% by weight of the total weight of the second unit.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 97.0
- Lexical Diversity: 1.13158
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13990861', '15912438', '14238961', '16029239', '16058769']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.711725075587764
- 35 USC 102 Novelty (BERT): 0.4762917038944324
- Combined Prediction Score: 0.6881817384184309
- Mean Citation Score: 164.92661200000003
- Max Citation Score: 166.32453999999996
- Similarity Product: 122.3691197963464

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test